The somatic silence or down-regulation of ASS1 expression are very common in various of tumors, including melanoma, prostate cancer, breast cancer, bladder cancer, mesothelioma, pancreatic cancer, nasopharyngeal carcinoma, osteosarcomas, and myxofibrosarcomas3–6. Here, ASS1 is linked to pancreatic neoplasm.